NOXCOVID has been cleared to recruit patients for the 800 mg and...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    NOXCOVID has been cleared to recruit patients for the 800 mg and 1200 mg cohorts, which means that there were no safety concerns with the 400 mg and 600 mg groups. The announcement did not comment on efficacy.

    On the same day, Noxopharm announced the formation of a dedicated subsidiary to exploit its STING-inhibition technology.

    Coincidence?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.8¢
Change
0.000(0.00%)
Mkt cap ! $28.63M
Open High Low Value Volume
9.7¢ 9.8¢ 9.5¢ $15.43K 159.9K

Buyers (Bids)

No. Vol. Price($)
1 47773 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 47899 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.